Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.

Fotaki G, Jin C, Kerzeli IK, Ramachandran M, Martikainen MM, Karlsson-Parra A, Yu D, Essand M

Oncoimmunology 7 (3) e1397250 [2017-12-26; online 2017-12-26]

Autologous patient-derived dendritic cells (DCs) modified

Affiliated researcher

PubMed 29399398

DOI 10.1080/2162402X.2017.1397250

Crossref 10.1080/2162402X.2017.1397250

pii: 1397250
pmc: PMC5790347

Publications 9.5.0